Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
First Opinion

STAT Plus video chat: What we know about Gilead’s remdesivir data

Thank you for your interest in this STAT video chat.

If you are not able to join the Zoom webinar directly because we have reached capacity, you can still watch the conversation via livestream here.

If you were able to participate in the Zoom webinar, please tell us what you thought by taking the quick survey below. Video chats are new for STAT, and we want to be sure we’re delivering insightful presentations that you find useful.

 

*Required

Why did you choose to attend this video chat? Check all that apply.*
Would you like to see STAT host more video chats like this in the future?*
This is the first time we've hosted a chat with one-hour notice for subscribers. What did you think?*

Which, if any, of the following features did you take advantage of in the Zoom platform during the video chat?*
What time of day would you prefer to attend a video chat like this?*
Privacy Policy